drugset / Trial / NCT06389318

Buccal Midazolam Versus Intranasal Dexmedetomidine Plus Oral Chloral Hydrate in Inguinal Hernia Repair

NCT06389318

Completed 80 enrolled Benha University
RandomizedParallel-groupDouble-blindPrevention

Summary

Inguinal hernia surgery is one of the most common surgical procedures in early infancy. Preoperative anxiety remains a vexing issue, and it exists in nearly 50% of pediatric patients

Timeline

Start
2023-03-26
Primary completion
2024-03-26
Completion
2024-04-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Chloral Hydrate Small molecule 50 mg/kg Oral
Subject Dexmedetomidine Other / unclassified 2 ug/kg Intranasal
Subject Midazolam Small molecule 0.1 mg/kg Other